PRL and lung cancer: The most significant five representative terms included one Canonical Pathways term, two KEGG Pathway terms and two Reactome Gene Sets terms, such as PID PTP1B PATHWAY (M50), Prolactin signaling pathway (hsa04917), Non‐small cell lung cancer (hsa05223), Extra‐nuclear estrogen signaling (R‐HSA‐9009391) and PIP3 activates AKT signaling (R‐HSA‐1257604).